MedTrace Logo

Medical Data Collection in the Formation of Precision Oncology Registry

NCT03874065 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2885

Last updated 2024-01-19

No results posted yet for this study

Summary

In efforts to develop an aggregation point for patient clinical data and data related to DNA sequencing in the Comprehensive Cancer Center, this registry will be developed to provide a comprehensive data store. The goal of the registry will be to collect information on the Cancer Center population undergoing next generation DNA sequencing (NGS) on their tumors or liquid biopsies.

Conditions

Interventions

OTHER

Medical Chart Review

Collection of data from participant's medical chart

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Stefan Grant, MD · Wake Forest University Health Sciences

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-17
Primary Completion
2024-01-11
Completion
2024-01-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03874065 on ClinicalTrials.gov